Kingsview Wealth Management
ICPT

Kingsview Wealth Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Kingsview Wealth Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,100
Closed -$187K – 1037
2023
Q3 		$187K Buy
+10,100
New +$114K 0.01% 893

Kingsview Wealth Management's ICPT Position: Q4 2023 in Review

Kingsview Wealth Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 10,100 shares — an estimated $187K sold.

Kingsview Wealth Management first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $187K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Kingsview Wealth Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Kingsview Wealth Management sold 10,100 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $187K.
  • Kingsview Wealth Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
  • Kingsview Wealth Management's Intercept Pharmaceuticals, Inc. position peaked at $187K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Kingsview Wealth Management's 13F filing for Q4 2023, filed 8 Feb 2024.